Form 4: Streamline Health Solutions Director Acquires 250,000 Shares of Restricted Stock
SEC Form 4 Filing
Justin John Ferayorni, a director of Streamline Health Solutions, acquired 250,000 shares of restricted stock on July 18, 2024, vesting in full by July 18, 2025, or earlier under certain conditions.
Summary
- Justin John Ferayorni, a director of Streamline Health Solutions Inc., filed a Form 4 on July 19, 2024, reporting a transaction.
- On July 18, 2024, Ferayorni acquired 250,000 shares of restricted common stock at a price of $0.50 per share.
- These shares vest in full on the earlier of July 18, 2025, or the date immediately prior to the issuer's 2025 annual meeting of stockholders, contingent upon continuous service.
- Following the transaction, Ferayorni directly owns 833,633 shares of Streamline Health Solutions Inc.
- Ferayorni may also be deemed an indirect beneficial owner of 4,930,882 shares held by Tamarack Global Healthcare Fund, L.P. and Tamarack Global Healthcare Fund QP, L.P., but disclaims beneficial ownership for Section 16 purposes except to the extent of his pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a routine filing and doesn't provide substantial new information about the company's performance.
Positives
- A director's acquisition of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The vesting of the restricted stock is contingent upon the reporting person's continuous service through the vesting date, suggesting an incentive for continued involvement with the company.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's investment in the company, which is common in the healthcare technology sector.
Stakeholder Impact
- The acquisition of shares by a director could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 07/18/2024 | Date of transaction: Justin John Ferayorni acquired 250,000 shares of restricted stock. |
| 07/18/2025 | Vesting date for the restricted stock, contingent on continuous service, or earlier depending on the company's 2025 annual meeting date. |
| 07/19/2024 | Date the Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.